LOMBARDO, CARLA FLORINDA
 Distribuzione geografica
Continente #
NA - Nord America 69
AS - Asia 50
EU - Europa 29
SA - Sud America 15
AF - Africa 1
Totale 164
Nazione #
US - Stati Uniti d'America 67
SG - Singapore 21
BR - Brasile 11
VN - Vietnam 10
DE - Germania 7
HK - Hong Kong 7
RU - Federazione Russa 7
CN - Cina 6
AR - Argentina 4
GB - Regno Unito 3
SE - Svezia 3
IT - Italia 2
PL - Polonia 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
UZ - Uzbekistan 1
Totale 164
Città #
Ashburn 30
Singapore 11
Hong Kong 7
Munich 5
Woodbridge 4
Chandler 3
Fairfield 3
Nyköping 3
Seattle 3
Beijing 2
Dallas 2
Des Moines 2
Hanoi 2
Lawrence 2
Wilmington 2
Abidjan 1
Baghdad 1
Bari 1
Boston 1
Brasília 1
Caerphilly 1
Calchaquí 1
Campo Largo 1
Caucete 1
Chennai 1
Chicago 1
City of London 1
Concord 1
Curitibanos 1
Dhaka 1
Frankfurt am Main 1
Ho Chi Minh City 1
Houston 1
Huế 1
Iacanga 1
Indaiatuba 1
Jakarta 1
Juiz de Fora 1
Lutzingen 1
Mexico City 1
Montreal 1
Moscow 1
Ninh Bình 1
Paris 1
Paulista 1
Phúc Yên 1
Poplar 1
Posadas 1
Princeton 1
Quận Tân Phú 1
Ribeirão Pires 1
Riga 1
Roxbury 1
San Isidro 1
Sofia 1
Sokolac 1
São Paulo 1
Tashkent 1
Tokyo 1
Votorantim 1
Várzea Paulista 1
Vũng Tàu 1
Warsaw 1
Wroclaw 1
Wuhan 1
Wuxi 1
Totale 132
Nome #
Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis 83
Home working and physical activity during SARS-CoV-2 pandemic: A longitudinal cohort study 51
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 36
Totale 170
Categoria #
all - tutte 971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 8 0 2 1 2 0
2021/20229 0 0 0 0 0 1 3 0 1 0 2 2
2022/202310 2 3 1 0 0 1 1 0 1 0 1 0
2023/202423 0 3 0 0 3 0 1 14 0 0 1 1
2024/202537 1 0 2 1 0 7 2 5 0 1 5 13
2025/202678 24 12 7 14 16 5 0 0 0 0 0 0
Totale 170